Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
UBGEN is an Italian biotechnology company specializing in the development and manufacture of advanced biomaterials for regenerative medicine. The company focuses on bone substitutes and collagen membranes derived from xenogenic sources, primarily for use in dental, maxillofacial, and orthopedic surgery. Their product portfolio includes specialized grafts like Ross and Shelter, designed to facilitate natural tissue healing and bone volume restoration. UBGEN emphasizes high-quality manufacturing processes to ensure biocompatibility and clinical efficacy in complex reconstructive procedures. The company's solutions are utilized globally by clinicians to address bone defects and soft tissue augmentation needs. Their proprietary processing technology allows for the preservation of the natural collagen matrix within bone substitutes, enhancing the biological response.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on UBGEN.